These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 31325714)

  • 21. Association between exposures to brominated trihalomethanes, hepatic injury and type II diabetes mellitus.
    Makris KC; Andrianou XD; Charisiadis P; Burch JB; Seth RK; Ioannou A; Picolos M; Christophi CA; Chatterjee S
    Environ Int; 2016; 92-93():486-93. PubMed ID: 27173514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Determination of thiodiglycolic acid in urine with gas chromatography-mass spectrometer].
    Xiao Q; Fu Z; Meng C; Xuan Y; Qin W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2015 Jun; 33(6):474-6. PubMed ID: 26653390
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations between mercury exposure and the risk of nonalcoholic fatty liver disease (NAFLD) in US adolescents.
    Chen R; Xu Y; Xu C; Shu Y; Ma S; Lu C; Mo X
    Environ Sci Pollut Res Int; 2019 Oct; 26(30):31384-31391. PubMed ID: 31473923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-alcoholic fatty liver disease is associated with low-grade albuminuria in men without diabetes mellitus.
    Kang SH; Cho KH; Do JY
    Int J Med Sci; 2019; 16(2):285-291. PubMed ID: 30745809
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationship between Methyl Tertiary Butyl Ether Exposure and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Petrol Station Attendants in Southern China.
    Yang J; Wei Q; Peng X; Peng X; Yuan J; Hu D
    Int J Environ Res Public Health; 2016 Sep; 13(10):. PubMed ID: 27669281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Albanian overweight children.
    Kodhelaj K; Resuli B; Petrela E; Malaj V; Jaze H
    Minerva Pediatr; 2014 Feb; 66(1):23-30. PubMed ID: 24608579
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The association between serum fructosamine and random spot urine fructose levels with the severity of non-alcoholic fatty liver disease - an analytical cross-sectional study.
    Kamuzinzi H; Kgomo M; Rheeder P; Dada N; Bester P
    S Afr Med J; 2024 May; 114(6):e1748. PubMed ID: 39041504
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The association between non-alcoholic fatty liver disease and carotid atherosclerosis in subjects with within-reference range alanine aminotransferase levels.
    Kim KS; Oh HJ; Kim DJ; Kim SK; Park SW; Cho YW; Huh KB
    Endocr J; 2013; 60(12):1295-301. PubMed ID: 24047563
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between serum uric acid levels and hepatic steatosis in non-obese postmenopausal women.
    Liu PJ; Ma F; Lou HP; Zhu YN; Chen Y
    Climacteric; 2014 Dec; 17(6):692-9. PubMed ID: 24884478
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sensitive flame-photometric-detector analysis of thiodiglycolic acid in urine as a biological monitor of vinyl chloride.
    Chen ZY; Gu XR; Cui MZ; Zhu XX
    Int Arch Occup Environ Health; 1983; 52(3):281-4. PubMed ID: 6629516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exposure and risk assessment of urinary trans, trans-Muconic acid in school-age children in the vicinity of a petrochemical complex in Central Taiwan.
    Cheng PK; Ponnusamy VK; Prakasham K; Huang HI; Chang WT; Huang PC
    Front Public Health; 2023; 11():1234823. PubMed ID: 37732090
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ferritin as a key risk factor for nonalcoholic fatty liver disease in children with obesity.
    Zhang J; Cao J; Xu H; Dong G; Huang K; Wu W; Ye J; Fu J
    J Clin Lab Anal; 2021 Feb; 35(2):e23602. PubMed ID: 33249617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-alcoholic fatty liver disease prevalence among school-aged children and adolescents in Iran and its association with biochemical and anthropometric measures.
    Alavian SM; Mohammad-Alizadeh AH; Esna-Ashari F; Ardalan G; Hajarizadeh B
    Liver Int; 2009 Feb; 29(2):159-63. PubMed ID: 18492015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insecticide and metal exposures are associated with a surrogate biomarker for non-alcoholic fatty liver disease in the National Health and Nutrition Examination Survey 2003-2004.
    Wahlang B; Appana S; Falkner KC; McClain CJ; Brock G; Cave MC
    Environ Sci Pollut Res Int; 2020 Feb; 27(6):6476-6487. PubMed ID: 31873887
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between the serum levels of uric acid and alanine aminotransferase in a population-based cohort.
    Zelber-Sagi S; Ben-Assuli O; Rabinowich L; Goldstein A; Magid A; Shalev V; Shibolet O; Chodick G
    Liver Int; 2015 Nov; 35(11):2408-15. PubMed ID: 25845417
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carotid intima-media thickness and flow-mediated dilation in obese children with non-alcoholic fatty liver disease.
    Torun E; Aydın S; Gökçe S; Özgen İT; Donmez T; Cesur Y
    Turk J Gastroenterol; 2014 Dec; 25 Suppl 1():92-8. PubMed ID: 25910377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urinary (1)H-NMR-based metabolic profiling of children with NAFLD undergoing VSL#3 treatment.
    Miccheli A; Capuani G; Marini F; Tomassini A; Praticò G; Ceccarelli S; Gnani D; Baviera G; Alisi A; Putignani L; Nobili V
    Int J Obes (Lond); 2015 Jul; 39(7):1118-25. PubMed ID: 25809828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of effects of obesity and non-alcoholic fatty liver disease on incidence of type 2 diabetes mellitus.
    Li WD; Fu KF; Li GM; Lian YS; Ren AM; Chen YJ; Xia JR
    World J Gastroenterol; 2015 Aug; 21(32):9607-13. PubMed ID: 26327768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
    Li XD; Qiu BH; Su FC; Sun SX
    Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease.
    Zhang S; Du T; Zhang J; Lu H; Lin X; Xie J; Yang Y; Yu X
    Lipids Health Dis; 2017 Jan; 16(1):15. PubMed ID: 28103934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.